Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002276 · ClinicalTrials.gov registry record · NA
The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia
A NA study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
NCT00002276 is a NA study that has completed, run by University of Pittsburgh.
The verdict
NCT00002276, a NA study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To determine if platelet dysfunction and/or pharmacologic drug interaction occurs in patients taking both AZT and ibuprofen, which might account for enhanced bleeding tendency.
Interventions
- DRUG Ibuprofen
- DRUG Zidovudine
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002276
The ClinicalTrials.gov registry entry for NCT00002276 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ibuprofen is the first listed.
NCT00002276 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002276 about?
NCT00002276 is a clinical study titled "The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia". To determine if platelet dysfunction and/or pharmacologic drug interaction occurs in patients taking both AZT and ibuprofen, which might account for enhanced bleeding tendency.
What is the current status of trial NCT00002276?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002276?
The interventions under investigation include: Ibuprofen (DRUG), Zidovudine (DRUG).
Who is sponsoring clinical trial NCT00002276?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.